We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 22, 2019

Multigene Testing for All Patients With Breast Cancer Is Cost-Effective

JAMA Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Oncology
A Cost-Effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
JAMA Oncol 2019 Oct 03;[EPub Ahead of Print], L Sun, A Brentnall, S Patel, DSM Buist, EJA Bowles, DGR Evans, D Eccles, J Hopper, S Li, M Southey, S Duffy, J Cuzick, I Dos Santos Silva, A Miners, Z Sadique, L Yang, R Legood, R Manchanda

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading